Dividend-adjusted total return · S&P 500 uses VOO · Oct 5, 2026 – Nov 3, 2026IBDS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +0.1% | +1.5% | −0.7% | −0.5% | +1.2% | +18.2% | +6.8% | +19.7% |
| Peer average | −0.1% | +1.1% | −0.6% | +0.1% | +0.8% | +19.8% | +5.5% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $480M
- Expense ratio
- 0.41%
- Distribution yield
- 4.4%
- NAV
- $23.28
- Volume
- 64K
- Avg. volume 30D
- 129K
- High today
- $23.27
- Low today
- $23.18
- Previous close
- $23.23
- 52-week high
- $24.78
- 52-week low
- $22.50
- Our risk indicator
- 2/5
IBD in One Breath
IBD Among Corporate ETFs
YTDEnd-of-day Nov 4, 2026 · 139 Corporate ETFs by YTD
$10,000 in IBD
5Y$10,000 in IBD became
$10,680
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
IBD’s Top Holdings
TodayAZO 3 3/4 06/0AZO 3 3/4 06/01/272.3%VLO 4.35 06/2.3%APH 4.35 06/2.3%ARE 4.9 12/12.3%CPT 4.9 01/12.2%GEV 4 7/8 022.2%MDLZ 4 3/4 02.2%SUI 2.3 11/02.2%MSCI 5 1/4 02.2%ADP 4.45 09/2.2%JBL 3.6 01/12.2%EVRG 2.9 09/2.2%CAT 2.6 09/12.2%ATO 2 5/8 092.2%CSL 2 3/4 032.2%FANG 3 1/8 02.1%MKC 2 1/2 042.1%BXP 3 1/4 012.1%AMCR 2.69 052.1%SWK 3 05/15/2.1%EXR 2.55 06/2.1%FTNT 2.2 03/2.0%
AZO 3 3/4 06/0AZO 3 3/4 06/01/272.3%VLO 4.35 06/2.3%APH 4.35 06/2.3%ARE 4.9 12/12.3%CPT 4.9 01/12.2%GEV 4 7/8 022.2%MDLZ 4 3/4 02.2%SUI 2.3 11/02.2%MSCI 5 1/4 02.2%ADP 4.45 09/2.2%JBL 3.6 01/12.2%EVRG 2.9 09/2.2%
Inspire IBD · 12 holdings · tile size = share of the fund · as of Nov 3, 2026
What IBD Holds
TodayAll holdings100.0%
AZO 3 3/4 2.3 · VLO 4.35 0 2.3 · APH 4.35 0 2.3 · ARE 4.9 12 2.3 · CPT 4.9 01 2.2 · GEV 4 7/8 2.2 · MDLZ 4 3/4 2.2
Inspire IBD · share of the fund · as of Nov 3, 2026
AZO’s Share of IBD
Today2.3%
$23 of every $1,000 in IBD is AZO
AZO held by IBD
$11.1M
Inspire IBD · each square = $10 of $1,000 · as of Nov 3, 2026
IBD’s Share of Corporate ETFs
Today0.1%
of the $396B in 169 Corporate ETFs
$480M0.1%
$66.6B16.8%
$43.9B11.1%
$285B72.0%
Corporate ETF AUM · Nov 4, 2026
IBD Fee per $100 vs Peers
TodayExpense ratio · Corporate peers · Nov 4, 2026
Inside IBD
12 holdings · as of Nov 3, 2026IBD
Inspire Corporate Bond ETF
TodayAll holdings100.0%AZO 3 3/4 2.3%VLO 4.35 02.3%APH 4.35 02.3%ARE 4.9 122.3%CPT 4.9 012.2%GEV 4 7/8 2.2%Mdlz 4 3/42.2%SUI 2.3 112.2%Msci 5 1/42.2%ADP 4.45 02.2%JBL 3.6 012.2%Evrg 2.9 02.2%86 more holdings68.8% of the fund
All holdings100.0%94 more holdings86.3% of the fund
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | — | AZO 3 3/4 06/01/27 | 2.32% |
| 2 | — | VLO 4.35 06/01/28 | 2.31% |
| 3 | — | APH 4.35 06/01/29 | 2.30% |
| 4 | — | ARE 4.9 12/15/30 | 2.28% |
| 5 | — | CPT 4.9 01/15/34 | 2.24% |
| 6 | — | GEV 4 7/8 02/04/36 | 2.22% |
| 7 | — | Mdlz 4 3/4 08/28/34 | 2.21% |
| 8 | — | SUI 2.3 11/01/28 | 2.21% |
| 9 | — | Msci 5 1/4 09/01/35 | 2.21% |
| 10 | — | ADP 4.45 09/09/34 | 2.20% |
Inspire IBD · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 43.9%
How It Compares
IBD
Inspire Corporate Bond ETF’s Peers
YTDCorporate peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put IBD head to head with VCIT →VCIT vs IBD
YTDYear to date
IBD wins+1.0 pt
Past year
IBD wins+1.9 pts
Fee
VCIT winslower fee
Yield
VCIT wins+0.6 pts
AUM
VCIT138.9× more
2–2level
Vanguard VCIT and Inspire IBD · year-to-date · as of Nov 4, 2026 · AUM not scored
IBD vs VOO
YTDIBD · Inspire Corporate Bond
−0.5%
VOO · S&P 500
+11.5%
Gap
12.1 pts
Inspire IBD and Vanguard VOO · YTD total return · as of Nov 4, 2026
IBD vs Its Peer Average
YTDIBDAvsBPeer average
1D+0.1%−0.1%
1M+1.5%+1.1%
3M−0.7%−0.6%
YTD−0.5%+0.1%
1Y+1.2%+0.8%
3Y+18.2%+19.8%
5Y+6.8%+5.5%
4–3IBD wins
168 Corporate peers · each row scaled to its leader
The Details
IBD
Risk
1Y2/5our risk indicator
CalmerBumpier
Volatility · 1Y4.32%
Deepest drop · 1Y−2.8%
Lowest point · 5Y−12.0%
52-week range
$23.25
$22.50−6.2% from the high$24.78
Inspire IBD · past-year price moves · as of Nov 4, 2026
IBD
Fund Facts
Today2017launched Jul 10
Tracks[…]
Exchange · CUSIPAMEX · 66538H633
StructureETF
Leverage1x
Cost on $10,000$41 a year
Go deeper
Inspire IBD · fund facts · as of Nov 4, 2026
IBD
Payouts by Year
6Y$0.10per share, Oct 2026
Distribution yield4.4%
PaidEvery month
Latest ex-date · paidOct 28 · Nov 2, 2026
12 payouts added up$1.03 a share
Inspire IBD · distributions by ex-date · 2021–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-11-30 ↗SEC reported portfolio · 2024-08-31 ↗prospectus · SEC 497 ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗SEC reported portfolio · 2023-08-31 ↗
Trading & Liquidity
Net asset value$23.28
Premium / discount[…]
Median spread · 30D[…]
Volume today64K
Average volume · 30D129K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.41%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$41.00
Our risk indicator2/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Oct 28, 2026 | Nov 2, 2026 | $0.10 |
| Sep 25, 2026 | Oct 1, 2026 | $0.0820 |
| Aug 26, 2026 | Aug 31, 2026 | $0.0904 |
| Jul 24, 2026 | Jul 29, 2026 | $0.0762 |
| Jun 26, 2026 | Jul 1, 2026 | $0.0959 |
| May 22, 2026 | May 27, 2026 | $0.0776 |
| Apr 24, 2026 | Apr 29, 2026 | $0.0788 |
| Mar 27, 2026 | Apr 1, 2026 | $0.0932 |
| Feb 24, 2026 | Mar 2, 2026 | $0.0779 |
| Jan 27, 2026 | Feb 2, 2026 | $0.0592 |
| Dec 17, 2025 | Dec 24, 2025 | $0.12 |
| Nov 21, 2025 | Nov 26, 2025 | $0.0729 |
Issuer contentFrom InspireHear the strategy from the people behind IBD.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →